No Data
No Data
Portage Biotech Inc. Announces New Director Compensation Plan and Stock Option Grants
Express News | Portage Biotech : Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective a2a and A2B Antagonists in Patients
Portage Biotech Resumes Enrollment In Final Cohort Of Dose Escalation For Port-6 In ADPORT-601 Trial
Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements
Express News | Portage Biotech Announces Completion of $2.15 Million Private Financing
Press Release: Portage Biotech Announces Completion of $2.15 Million Private Financing